Source 1primary paper2026MED
Toolkit/high-turbulence microreactor
high-turbulence microreactor
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
We compared three manufacturing methods for diclofenac-loaded liposomes: probe sonication, microfluidic mixing, and a high-turbulence microreactor.
Usefulness & Problems
No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.
Published Workflows
Objective: Compare and optimize three manufacturing routes for diclofenac-loaded liposomes under a Quality-by-Design framework to achieve scalable, well-controlled production meeting topical critical quality attributes.
Why it works: The workflow first defines a processing-relevant thermal window, then tunes route-specific process variables and monitors post-processing solvent while checking final size, dispersity, encapsulation, and morphology against topical CQAs.
processing within a liquid-crystalline temperature window for lipid excipientsenergy-density-controlled sonication scale-upFRR/TFR-controlled microfluidic liposome formationhigh-turbulence mixing for elevated-throughput liposome formationQuality-by-Design frameworkPlackett-Burman screening designdesirability-function optimizationat-line Raman monitoring calibrated against GCDLS characterizationcryo-TEM characterization
Stages
- 1.DSC-defined processing window(functional_characterization)
This stage establishes the temperature window used to guide downstream manufacturing conditions.
Selection: Define a processing-relevant liquid-crystalline temperature window for the lipid excipients.
- 2.Sonication factor screening and scale-up control(broad_screen)
This stage narrows sonication conditions to those that can be controlled during scale-up.
Selection: Identify key process factors for sonication scale-up and support an energy-density control approach.
- 3.Microfluidic FRR/TFR mapping and optimization(broad_screen)
This stage identifies microfluidic operating conditions that best satisfy the desired liposome quality profile.
Selection: Map the effects of FRR and TFR and optimize them using a desirability function.
- 4.High-throughput microreactor trials(functional_characterization)
This stage tests whether a high-turbulence microreactor can deliver acceptable liposome quality at higher throughput.
Selection: Evaluate microreactor performance at elevated throughput.
- 5.Residual ethanol monitoring during post-processing(secondary_characterization)
This stage provides process monitoring for residual solvent during post-processing.
Selection: Monitor residual ethanol at-line during post-processing using Raman spectroscopy calibrated against GC.
- 6.Final particle and morphology characterization(confirmatory_validation)
This stage confirms whether manufactured liposomes meet the intended quality attributes and lack evident aggregates.
Selection: Measure particle size and dispersity by DLS and assess morphology by cryo-TEM.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete method used to build, optimize, or evolve an engineered system.
Mechanisms
high-turbulence mixingTechniques
Selection / EnrichmentTarget processes
manufacturingselectionValidation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Method selection should be guided by target size, dispersity, and operational constraints because sonication enables energy-based scale-up, microfluidics offers precise size control, and microreactors provide higher throughput.
Method selection should be guided by target size/dispersity and operational constraints: sonication enables energy-based scale-up, microfluidics offers precise size control, and microreactors provide higher throughput.
Microfluidics optimization selected FRR 3:1 and TFR 4 mL·min^-1, yielding about 64 nm liposomes with PDI about 0.13 and encapsulation efficiency about 93%.
Microfluidics optimization selected FRR 3:1/TFR 4 mL·min^-1, yielding ~64 nm liposomes with PDI ~0.13 and %EE ~93%.
encapsulation efficiency 93 %flow-rate ratio 3:1liposome size 64 nmPDI 0.13total flow rate 4 mL·min^-1
All three manufacturing routes met topical critical quality attributes for diclofenac-loaded liposomes, including about 50-100 nm size, PDI less than or equal to 0.30, and high encapsulation efficiency.
All three routes met topical CQAs (~50-100 nm; PDI ≤ 0.30; high %EE).
encapsulation efficiency highPDI 0.3target size range ~50-100 nm
The high-turbulence microreactor achieved about 50 nm liposomes with about 95% encapsulation efficiency at 50 mL·min^-1.
The microreactor achieved ~50 nm liposomes with %EE ~95% at 50 mL·min^-1.
encapsulation efficiency 95 %liposome size 50 nmthroughput 50 mL·min^-1
Sonication scale-up using an energy-density target of about 11,000 W·s·L^-1 reproduced lab-scale liposome quality at 8 L.
Sonication scale-up using an energy-density target (~11,000 W·s·L^-1) reproduced lab-scale quality at 8 L (Z-average ~87-92 nm; PDI 0.16-0.23; %EE 86-94%).
encapsulation efficiency 86-94 %energy density target 11000 W·s·L^-1PDI 0.16-0.23scale 8 LZ-average size ~87-92 nm
Approval Evidence
1 source3 linked approval claimsfirst-pass slug high-turbulence-microreactor
We compared three manufacturing methods for diclofenac-loaded liposomes: probe sonication, microfluidic mixing, and a high-turbulence microreactor.
Source:
comparative tradeoffsupports
Method selection should be guided by target size, dispersity, and operational constraints because sonication enables energy-based scale-up, microfluidics offers precise size control, and microreactors provide higher throughput.
Method selection should be guided by target size/dispersity and operational constraints: sonication enables energy-based scale-up, microfluidics offers precise size control, and microreactors provide higher throughput.
Source:
performance summarysupports
All three manufacturing routes met topical critical quality attributes for diclofenac-loaded liposomes, including about 50-100 nm size, PDI less than or equal to 0.30, and high encapsulation efficiency.
All three routes met topical CQAs (~50-100 nm; PDI ≤ 0.30; high %EE).
Source:
performance summarysupports
The high-turbulence microreactor achieved about 50 nm liposomes with about 95% encapsulation efficiency at 50 mL·min^-1.
The microreactor achieved ~50 nm liposomes with %EE ~95% at 50 mL·min^-1.
Source:
Comparisons
No literature-backed comparison notes have been materialized for this record yet.
Ranked Citations
- 1.